UNRESECTABLE BREAST CARCINOMA
Clinical trials for UNRESECTABLE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control Recruiting nowThis study tests two experimental drugs, BNT323 and BNT327, together in people with advanced breast cancer that has spread or cannot be removed. The goal is to see if the combination can shrink tumors and control the disease. About 380 adults with specific HER2-positive, HER2-low…
Matched conditions: UNRESECTABLE BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 16, 2026 22:29 UTC
-
New drug cocktail aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis early-phase trial tests two drugs—ZEN003694 and abemaciclib—together in people with advanced NUT carcinoma, breast cancer, or other solid tumors that have spread or can't be removed. The main goals are to find the safest dose and see if the combination can shrink or stabiliz…
Matched conditions: UNRESECTABLE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 22:28 UTC
-
New drug duo targets hard-to-treat HER2 cancers in early trial
Disease control Recruiting nowThis early-phase trial tests the safety and best dose of two drugs given together for people with advanced breast cancer or other solid tumors that have a protein called HER2. The drugs are pidnarulex (which stops cancer cells from repairing themselves) and trastuzumab deruxtecan…
Matched conditions: UNRESECTABLE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Virtual Check-Ins aim to ease End-of-Life care for breast cancer patients
Symptom relief Recruiting nowThis study explores whether regular video or phone check-ins between patients with advanced breast cancer, their caregivers, and their cancer care teams can improve the hospice experience. About 200 participants receiving in-home hospice care in Massachusetts will take part. The …
Matched conditions: UNRESECTABLE BREAST CARCINOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC